Patents by Inventor Rodney Ketner

Rodney Ketner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amorphous Cyclodextrin Compositions
    Publication number: 20080003296
    Abstract: Compositions are disclosed that comprise a plurality of particles of a cyclodextrin and a water-soluble polymer wherein the cyclodextrin is in intimate contact with the polymer and a major portion of the cyclodextrin in the particles is amorphous.
    Type: Application
    Filed: July 11, 2005
    Publication date: January 3, 2008
    Inventor: Rodney Ketner
  • Pharmaceutical Compositions of Dispersions of Drugs and Neutral Polymers
    Publication number: 20060216351
    Abstract: In one aspect, pharmaceutical compositions comprising dispersions of an acid-sensitive drug and a neutral dispersion polymer are disclosed. The acid-sensitive drug has improved chemical stability relative to dispersions of the drug and acidic polymers. In another aspect, pharmaceutical compositions of low-solubility drugs and amphiphilic, hydroxy-functional vinyl copolymers are disclosed.
    Type: Application
    Filed: May 16, 2006
    Publication date: September 28, 2006
    Inventors: Dwayne Friesen, Michael Gumkowski, Rodney Ketner, Douglas Lorenz, James Nightingale, Ravi Shanker, James West
  • Pharmaceutical Compositions of Drugs and Neutralized Acidic Polymers
    Publication number: 20060204577
    Abstract: Pharmaceutical compositions comprised of low-solubility and/or acid-sensitive drugs and neutralized acidic polymers are disclosed.
    Type: Application
    Filed: June 5, 2006
    Publication date: September 14, 2006
    Inventors: Marshall Crew, Dwayne Friesen, Rodney Ketner, Ravi Shanker, James West
  • Pharmaceutical compositions of drugs and neutralized acidic polymers
    Publication number: 20060003011
    Abstract: Pharmaceutical compositions comprised of low-solubility and/or acid-sensitive drugs and neutralized acidic polymers are disclosed.
    Type: Application
    Filed: August 26, 2005
    Publication date: January 5, 2006
    Inventors: Marshall Crew, Dwayne Friesen, Rodney Ketner, Ravi Shanker, James West
  • Compositions comprising an HIV protease inhibitor
    Publication number: 20050129772
    Abstract: The present invention relates to pharmaceutical compositions comprising amorphous (4R)—N-allyl-3-{(2S,3S)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylbutanoyl}-5,5-dimethyl-1,3-thiazolidine-4-carboxamide, or a pharmaceutically acceptable salt or solvate thereof, their methods of preparation, their use in inhibiting the HIV protease enzyme, and their use in treating HIV-infected mammals, such as humans.
    Type: Application
    Filed: December 8, 2004
    Publication date: June 16, 2005
    Inventors: Scott Smith, Dwayne Friesen, Douglas Lorenz, David Lyon, Rodney Ketner, James West